Y mAbs Therapeutics (YMAB) Q3 2023 Earnings

13NovConfirmed
Nov 22
Q1 2023
Q2 2023
Q3 2023
-0.71
-0.46
-0.22
0.03

Details

Expected EPS
-0.19
Actual EPS
-0.18
Surprise EPS
0.01
Surprise Percent
+5.26%

Description

Y mAbs Therapeutics (YMAB) has reported earnings of -0.18 per share for Q3 2023.

0 Comments

Share your thoughts